A. Stefos

发表

Evaluation of rapid polymyxin NP test to detect colistin-resistant Klebsiella pneumoniae isolated in a tertiary Greek hospital.

E. Petinaki, C. Papagiannitsis, E. Malli, 2018, Journal of microbiological methods.

Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19

M. Vlychou, E. Giamarellos‐Bourboulis, G. Dalekos, 2021, European Journal of Internal Medicine.

Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece.

C. Hadjichristodoulou, E. Rigopoulou, G. Dalekos, 2009, European journal of internal medicine.

Reversion of severe hepatopulmonary syndrome in a non cirrhotic patient after corticosteroid treatment for granulomatous hepatitis: a case report and review of the literature.

I. Skoularigis, E. Rigopoulou, G. Dalekos, 2006, World journal of gastroenterology.

Leptospirosis and pancytopenia: two case reports and review of the literature.

S. Pournaras, G. Dalekos, A. Stefos, 2005, The Journal of infection.

Risk factors associated with HCV infection in semi-rural areas of central Greece.

E. Rigopoulou, G. Dalekos, A. Stefos, 2007, European journal of internal medicine.

Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

M. Netea, G. Chatellier, M. Sormani, 2021, The Lancet Rheumatology.

SERIAL ANALYSIS OF AUTOANTIBODIES IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS

G. Norman, G. Dalekos, A. Stefos, 2011 .

Plethora of Resistance Genes in Carbapenem-Resistant Gram-Negative Bacteria in Greece: No End to a Continuous Genetic Evolution

S. Monecke, R. Ehricht, V. Spyrou, 2022, Microorganisms.

Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients

K. Antoniou, D. Sagris, G. Dalekos, 2022, Viruses.

Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece.

G. Spanakos, N. Sipsas, G. Dalekos, 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.

Christos G Gogos, K. Arvaniti, G. Daikos, 2020, The Journal of antimicrobial chemotherapy.

Unusual cardiovascular complications of brucellosis presenting in two men: two case reports and a review of the literature

G. Dalekos, K. Makaritsis, A. Stefos, 2011, Journal of medical case reports.

Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions

E. Rigopoulou, G. Dalekos, K. Makaritsis, 2019, World journal of clinical cases.

Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome.

I. Fezoulidis, G. Dalekos, K. Makaritsis, 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Rifampicin: not always an innocent drug

E. Rigopoulou, G. Dalekos, A. Stefos, 2018, BMJ Case Reports.

Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: A hidden threat.

P. Boura, G. Dalekos, A. Sarantopoulos, 2013, World journal of hepatology.

MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19

C. Hadjichristodoulou, V. Mouchtouri, G. Germanidis, 2021, Immunobiology.

An open label trial of anakinra to prevent respiratory failure in COVID-19

M. Netea, H. Milionis, J. van der Meer, 2020, medRxiv.

Diabetes on sepsis outcomes in non-ICU patients: A cohort study and review of the literature.

N. Rovina, E. Giamarellos‐Bourboulis, K. Akinosoglou, 2020, Journal of diabetes and its complications.

Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

Nikolaos A. Triarides, H. Goossens, A. Georgescu, 2023, EClinicalMedicine.

Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infection

E. Giamarellos‐Bourboulis, K. Toutouzas, K. Akinosoglou, 2018, BMC Infectious Diseases.

SURVIVAL BENEFIT ASSOCIATED WITH CLARITHROMYCIN IN SEVERE COMMUNITY-ACQUIRED PNEUMONIA: A MATCHED COMPARATOR STUDY.

M. Niederman, E. Giamarellos‐Bourboulis, M. Pavlaki, 2019, International journal of antimicrobial agents.

Osteonecrosis risk after steroids-related treatment of COVID-19 is not negligible: A cross sectional study.

G. Dalekos, A. Stefos, N. Gatselis, 2024, European journal of internal medicine.